2021年7月21日简报:北京成人疫苗接种超过95%,启动12-17岁接种新冠疫苗,全球低收入国家疫苗接种达1亿剂

2021-07-21 MedSci整理 MedSci整理

截至北京时间2021年7月21日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过19219万例,新增479,423例,达到192,196,43

截至北京时间2021年7月21日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过19219万例,新增479,423例,达到192,196,439例。累计死亡病例412.3万例,达到4,123,795例。新增死亡为7,607例。康复为174,846,623例,重症和危重症病人达到81,861例;全球新冠确诊病例超过100万例的国家达29个,98个国家病例超10万例。昨日报道:2021年7月20日简报:云南两日新增本土病例13例,云南加快新冠疫苗接种,中国又有两款疫苗获批临床试验,欧洲病例超5000万

罗氏与再生日的双抗体疗法获多国批准

罗氏(Roche)宣布,日本厚生劳动省(MHLW)已批准抗体鸡尾酒疗法Ronapreve(casirivimab和imdevimab,前称:REGN-COV2)该药通过静脉输注,用于治疗轻度至中度COVID-19患者

该药是由2种单抗(casirivimab和imdevimab)组成的一种鸡尾酒疗法,2种单抗分别针对新型冠状病毒(SARS-CoV-2)棘突蛋白(S蛋白)受体结合区域的2个独立的、不重叠的位点,具有协同作用,可降低病毒变异逃逸的风险,并保护人群免受S蛋白发生突变的病毒变体的侵害。此外,来自临床前研究的数据表明,casirivimab和imdevimab保留了针对关键的新兴变体的中和活性。

在日本以外的其他地区,包括欧盟、美国、印度、瑞士和加拿大,casirivimab和imdevimab鸡尾酒疗法已被授权用于紧急使用或临时大流行使用。在欧盟,欧洲药品管理局(EMA)正在对casirivimab和imdevimab鸡尾酒疗法进行滚动审查,其下设机构人用药品委员会(CHMP)已发布了积极的科学意见,支持将casirivimab和imdevimab鸡尾酒疗法作为一种治疗选择,用于治疗确诊COVID-19、不需要补氧、有高风险发展为严重COVID-19的患者。

北京启动12-17岁人群新冠疫苗接种

按照国家整体部署,北京市7月20日全面启动12-17岁人群新冠病毒疫苗接种。

覆盖在京12-17岁人群(接种时需年满12周岁),含在校学生(包括小学、普通中学、大学、中专学校、职业高中、技工学校、工读学校、特殊教育学校等教育机构的学生)及非在校适龄人群。

北京市成人接种率高达95.6%

至7月20日12时,北京市累计报告接种新冠病毒疫苗3615.35万剂次,累计接种1862.06万人,其中1764.34万人完成全程接种,全市18岁及以上人群新冠疫苗第1剂接种率达到95.63%,全程接种率90.61%。

美众议院议长佩洛西助手确诊新冠,已接种疫苗

当地时间7月20日报道,有白宫官员证实,美国众议院议长南希·佩洛西的一名助手的新冠病毒检测结果呈阳性,19日曾有另一名白宫工作人员的新冠检测也呈阳性。

据报道,两人均未与美国总统拜登、众议院议长佩洛西产生密切接触,且这两人都已完全接种新冠疫苗。报道称,白宫的确诊病例反映了全美各地新冠病毒新增感染病例的持续激增,对政府官员及工作人员的健康状况也产生了威胁。

中国台湾高端公司所研发新冠疫苗19日获得紧急使用授权

中国台湾本土疫苗“高端”疫苗19日通过EUA(紧急使用授权)审查。中国台湾疫情指挥中心指挥官陈时中表示,预计八月可有少量的疫苗供台湾人施打。但数量的部分,还要等专家小组讨论后,再放到计划中。

由于三期临床试验没做完,外界对台湾本土“高端”疫苗疑虑重重。中国台湾“食药署”19日提出在高端疫苗组药效“数据漂亮”,但台湾“中研院院士”陈培哲却说,“这是没有用的数字,不具有任何参考价值,他连看都不想看。”放眼全球,也只有台湾这样做,可以说是另类的台湾第一。

这家公司主要从事牲畜类疫苗的制造,大陆很多养殖场使用的动物新冠疫苗均来自于高端公司。

全球新冠疫苗接种概况,低收入国家疫苗接种达1亿剂

Country
Cumulative COVID-19 vaccinationsdoses
World 3.70 billion
Asia 2.32 billion
Upper middle income 1.94 billion
China 1.47 billion
High income 1.12 billion
Lower middle income 625.05 million
Europe 597.80 million
North America 469.61 million
European Union 433.43 million
India 411.85 million
United States 338.25 million
South America 232.86 million
Brazil 124.91 million
Germany 86.52 million
United Kingdom Jul 18, 2021 82.41 million
Japan 71.92 million
England Jul 18, 2021 69.08 million
France 65.58 million
Turkey 63.86 million
Italy 62.14 million
Africa 61.06 million
Indonesia 58.50 million
Mexico Jul 18, 2021 54.54 million
Russia 52.92 million
Spain 51.71 million
Canada 45.68 million
Poland 32.92 million
Argentina 27.43 million
Chile Jul 17, 2021 24.76 million
Colombia Jul 18, 2021 23.63 million
Saudi Arabia 22.87 million
Pakistan Jul 17, 2021 22.74 million
South Korea 21.78 million
Morocco 21.29 million
Netherlands Jul 18, 2021 18.27 million
United Arab Emirates 16.38 million
Philippines 15.10 million
Malaysia 14.77 million
Thailand Jul 18, 2021 14.30 million
Belgium 13.09 million
Oceania 12.43 million
Israel 10.99 million
Portugal 10.97 million
Peru Jul 18, 2021 10.78 million
Low income 10.28 million
Hungary Jun 27, 2021 10.16 million
Australia 10.13 million
Bangladesh Jul 13, 2021 10.11 million
Cambodia Jul 18, 2021 10.04 million

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1954013, encodeId=e2221954013e5, content=<a href='/topic/show?id=1c6a262184c' target=_blank style='color:#2F92EE;'>#低收入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26218, encryptionId=1c6a262184c, topicName=低收入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Apr 06 13:27:43 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014478, encodeId=628910144e80d, content=为祖国自豪, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WkCOvOmryLdNWlc4E3oH5kEfJcsUjUyUNRvqjEd7NhGbIjAHqn3y3RDdqrHtkmtzmH1hGaVpqon8YDJhMFXsHQ/132, createdBy=f3525323014, createdName=HYL意连, createdTime=Sat Sep 04 07:31:17 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258062, encodeId=accd12580624f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jul 22 22:27:43 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029755, encodeId=0fe91029e554f, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 21 10:27:43 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001354, encodeId=903a10013543b, content=还是祖国厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210402/26822f5550074dd69e35066b30425201/458a7e6ac946411192355c0c3b72f574.jpg, createdBy=68285417733, createdName=ms2000000576998327, createdTime=Wed Jul 21 10:22:43 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1954013, encodeId=e2221954013e5, content=<a href='/topic/show?id=1c6a262184c' target=_blank style='color:#2F92EE;'>#低收入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26218, encryptionId=1c6a262184c, topicName=低收入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Apr 06 13:27:43 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014478, encodeId=628910144e80d, content=为祖国自豪, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WkCOvOmryLdNWlc4E3oH5kEfJcsUjUyUNRvqjEd7NhGbIjAHqn3y3RDdqrHtkmtzmH1hGaVpqon8YDJhMFXsHQ/132, createdBy=f3525323014, createdName=HYL意连, createdTime=Sat Sep 04 07:31:17 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258062, encodeId=accd12580624f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jul 22 22:27:43 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029755, encodeId=0fe91029e554f, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 21 10:27:43 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001354, encodeId=903a10013543b, content=还是祖国厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210402/26822f5550074dd69e35066b30425201/458a7e6ac946411192355c0c3b72f574.jpg, createdBy=68285417733, createdName=ms2000000576998327, createdTime=Wed Jul 21 10:22:43 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-09-04 HYL意连

    为祖国自豪

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1954013, encodeId=e2221954013e5, content=<a href='/topic/show?id=1c6a262184c' target=_blank style='color:#2F92EE;'>#低收入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26218, encryptionId=1c6a262184c, topicName=低收入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Apr 06 13:27:43 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014478, encodeId=628910144e80d, content=为祖国自豪, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WkCOvOmryLdNWlc4E3oH5kEfJcsUjUyUNRvqjEd7NhGbIjAHqn3y3RDdqrHtkmtzmH1hGaVpqon8YDJhMFXsHQ/132, createdBy=f3525323014, createdName=HYL意连, createdTime=Sat Sep 04 07:31:17 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258062, encodeId=accd12580624f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jul 22 22:27:43 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029755, encodeId=0fe91029e554f, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 21 10:27:43 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001354, encodeId=903a10013543b, content=还是祖国厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210402/26822f5550074dd69e35066b30425201/458a7e6ac946411192355c0c3b72f574.jpg, createdBy=68285417733, createdName=ms2000000576998327, createdTime=Wed Jul 21 10:22:43 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1954013, encodeId=e2221954013e5, content=<a href='/topic/show?id=1c6a262184c' target=_blank style='color:#2F92EE;'>#低收入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26218, encryptionId=1c6a262184c, topicName=低收入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Apr 06 13:27:43 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014478, encodeId=628910144e80d, content=为祖国自豪, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WkCOvOmryLdNWlc4E3oH5kEfJcsUjUyUNRvqjEd7NhGbIjAHqn3y3RDdqrHtkmtzmH1hGaVpqon8YDJhMFXsHQ/132, createdBy=f3525323014, createdName=HYL意连, createdTime=Sat Sep 04 07:31:17 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258062, encodeId=accd12580624f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jul 22 22:27:43 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029755, encodeId=0fe91029e554f, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 21 10:27:43 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001354, encodeId=903a10013543b, content=还是祖国厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210402/26822f5550074dd69e35066b30425201/458a7e6ac946411192355c0c3b72f574.jpg, createdBy=68285417733, createdName=ms2000000576998327, createdTime=Wed Jul 21 10:22:43 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-07-21 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1954013, encodeId=e2221954013e5, content=<a href='/topic/show?id=1c6a262184c' target=_blank style='color:#2F92EE;'>#低收入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26218, encryptionId=1c6a262184c, topicName=低收入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Wed Apr 06 13:27:43 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014478, encodeId=628910144e80d, content=为祖国自豪, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WkCOvOmryLdNWlc4E3oH5kEfJcsUjUyUNRvqjEd7NhGbIjAHqn3y3RDdqrHtkmtzmH1hGaVpqon8YDJhMFXsHQ/132, createdBy=f3525323014, createdName=HYL意连, createdTime=Sat Sep 04 07:31:17 CST 2021, time=2021-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258062, encodeId=accd12580624f, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jul 22 22:27:43 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029755, encodeId=0fe91029e554f, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 21 10:27:43 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001354, encodeId=903a10013543b, content=还是祖国厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210402/26822f5550074dd69e35066b30425201/458a7e6ac946411192355c0c3b72f574.jpg, createdBy=68285417733, createdName=ms2000000576998327, createdTime=Wed Jul 21 10:22:43 CST 2021, time=2021-07-21, status=1, ipAttribution=)]
    2021-07-21 ms2000000576998327

    还是祖国厉害

    0

相关资讯

2021年7月20日简报:云南两日新增本土病例13例,云南加快新冠疫苗接种,中国又有两款疫苗获批临床试验,欧洲病例超5000万

截至北京时间2021年7月20日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过19165万例,新增394,799例,达到191,656,70

2021年7月19日简报:新冠疫苗可能无法有效保护免疫力低下人群

截至北京时间2021年7月19日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过19118万例,新增432,931例,达到191,187,25

针对多种变异株 依生生物的皮卡重组蛋白新冠疫苗获批阿联酋临床

依生生物制药有限公司今天宣布依生生物自主研发的皮卡重组蛋白新型冠状病毒疫苗获得阿拉伯联合酋长国卫生和预防部批准开展I期临床试验。皮卡重组蛋白新型冠状病毒疫苗是由皮卡佐剂和重组三聚体SARS-CoV-2

2021年7月17日简报:中国生物新冠疫苗获批3-17岁人群中紧急使用,北京和上海成人接种率均超90%,复必泰8月底在国内试产

截至北京时间2021年7月17日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过19024万例,新增533,816例,达到190,241,17

2021年7月18日简报:以色列为高危成年人接种第三剂新冠疫苗,多个发达国家疫苗接种超60%,英国疫情快速恶化

截至北京时间2021年7月18日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过19074万例,新增473,963例,达到190,744,91

2021年7月16日简报:中国新冠疫苗接种超14亿剂,国内**mRNA新冠疫苗“复必泰”即将获批;印尼疫情爆发,日增超5万例

截至北京时间2021年7月16日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过18968万例,新增544,679例,达到189,686,62